Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease
There are limited contemporary data on guideline-directed medical therapy (GDMT) utilization and long-term clinical outcomes in patients with peripheral artery disease (PAD) with and without concomitant coronary artery disease (CAD). From 2006 to 2013, 879 patients with claudication or critical limb...
Saved in:
| Published in: | The American journal of cardiology Vol. 119; no. 8; pp. 1146 - 1152 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
Elsevier Inc
15.04.2017
Elsevier Limited |
| Subjects: | |
| ISSN: | 0002-9149, 1879-1913 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | There are limited contemporary data on guideline-directed medical therapy (GDMT) utilization and long-term clinical outcomes in patients with peripheral artery disease (PAD) with and without concomitant coronary artery disease (CAD). From 2006 to 2013, 879 patients with claudication or critical limb ischemia (CLI) underwent diagnostic angiography or therapeutic endovascular intervention at our multidisciplinary vascular center. GDMT use was assessed at the time of angiography, and major adverse cardiovascular and cerebrovascular events (MACCE) and all-cause mortality were determined during 5 years of follow-up. Cox proportional hazard modeling was used to adjust for baseline differences between patients with and without concomitant CAD. Despite a higher adherence to GDMT (all p ≤0.002) for the use of aspirin, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, and statins, patients with PAD and concomitant CAD had higher unadjusted 5-year rates of MACCE (hazard ratio [HR] 1.7, 95% CI 1.3 to 2.1, p = 0.0001) and all-cause mortality (HR 1.86, 95% CI 1.4 to 2.4, p = 0.0001). After adjustment for baseline co-morbidities, the presence of CAD remained an independent risk factor for mortality (adjusted HR 1.35, 95% CI 1.02 to 1.80, p = 0.04) but not for MACCE (adjusted HR 1.24, 95% CI 0.96 to 1.60, p = 0.10) in patients with PAD. A sensitivity analysis limited to patients with CLI demonstrated that concomitant CAD was associated with significantly higher adjusted rates of both MACCE (adjusted HR 1.52, 95% CI 1.14 to 2.03, p = 0.01) and mortality (adjusted HR 1.64, 95% CI 1.12 to 2.20, p = 0.006). In conclusion, despite higher rates of GDMT use, PAD patients with concomitant CAD had significantly increased risk of all-cause mortality during a 5-year postprocedural follow-up. The subgroup of CLI patients with concomitant CAD was at particularly high risk for both MACCE and all-cause mortality. |
|---|---|
| AbstractList | There are limited contemporary data on guideline-directed medical therapy (GDMT) utilization and long-term clinical outcomes in patients with peripheral artery disease (PAD) with and without concomitant coronary artery disease (CAD). From 2006 to 2013, 879 patients with claudication or critical limb ischemia (CLI) underwent diagnostic angiography or therapeutic endovascular intervention at our multidisciplinary vascular center. GDMT use was assessed at the time of angiography, and major adverse cardiovascular and cerebrovascular events (MACCE) and all-cause mortality were determined during 5 years of follow-up. Cox proportional hazard modeling was used to adjust for baseline differences between patients with and without concomitant CAD. Despite a higher adherence to GDMT (all p <=0.002) for the use of aspirin, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, and statins, patients with PAD and concomitant CAD had higher unadjusted 5-year rates of MACCE (hazard ratio [HR] 1.7, 95% CI 1.3 to 2.1, p = 0.0001) and all-cause mortality (HR 1.86, 95% CI 1.4 to 2.4, p = 0.0001). After adjustment for baseline co-morbidities, the presence of CAD remained an independent risk factor for mortality (adjusted HR 1.35, 95% CI 1.02 to 1.80, p = 0.04) but not for MACCE (adjusted HR 1.24, 95% CI 0.96 to 1.60, p = 0.10) in patients with PAD. A sensitivity analysis limited to patients with CLI demonstrated that concomitant CAD was associated with significantly higher adjusted rates of both MACCE (adjusted HR 1.52, 95% CI 1.14 to 2.03, p = 0.01) and mortality (adjusted HR 1.64, 95% CI 1.12 to 2.20, p = 0.006). In conclusion, despite higher rates of GDMT use, PAD patients with concomitant CAD had significantly increased risk of all-cause mortality during a 5-year postprocedural follow-up. The subgroup of CLI patients with concomitant CAD was at particularly high risk for both MACCE and all-cause mortality. There are limited contemporary data on guideline-directed medical therapy (GDMT) utilization and long-term clinical outcomes in patients with peripheral artery disease (PAD) with and without concomitant coronary artery disease (CAD). From 2006 to 2013, 879 patients with claudication or critical limb ischemia (CLI) underwent diagnostic angiography or therapeutic endovascular intervention at our multidisciplinary vascular center. GDMT use was assessed at the time of angiography, and major adverse cardiovascular and cerebrovascular events (MACCE) and all-cause mortality were determined during 5 years of follow-up. Cox proportional hazard modeling was used to adjust for baseline differences between patients with and without concomitant CAD. Despite a higher adherence to GDMT (all p ≤0.002) for the use of aspirin, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, and statins, patients with PAD and concomitant CAD had higher unadjusted 5-year rates of MACCE (hazard ratio [HR] 1.7, 95% CI 1.3 to 2.1, p = 0.0001) and all-cause mortality (HR 1.86, 95% CI 1.4 to 2.4, p = 0.0001). After adjustment for baseline co-morbidities, the presence of CAD remained an independent risk factor for mortality (adjusted HR 1.35, 95% CI 1.02 to 1.80, p = 0.04) but not for MACCE (adjusted HR 1.24, 95% CI 0.96 to 1.60, p = 0.10) in patients with PAD. A sensitivity analysis limited to patients with CLI demonstrated that concomitant CAD was associated with significantly higher adjusted rates of both MACCE (adjusted HR 1.52, 95% CI 1.14 to 2.03, p = 0.01) and mortality (adjusted HR 1.64, 95% CI 1.12 to 2.20, p = 0.006). In conclusion, despite higher rates of GDMT use, PAD patients with concomitant CAD had significantly increased risk of all-cause mortality during a 5-year postprocedural follow-up. The subgroup of CLI patients with concomitant CAD was at particularly high risk for both MACCE and all-cause mortality. There are limited contemporary data on guideline-directed medical therapy (GDMT) utilization and long-term clinical outcomes in patients with peripheral artery disease (PAD) with and without concomitant coronary artery disease (CAD). From 2006 to 2013, 879 patients with claudication or critical limb ischemia (CLI) underwent diagnostic angiography or therapeutic endovascular intervention at our multidisciplinary vascular center. GDMT use was assessed at the time of angiography, and major adverse cardiovascular and cerebrovascular events (MACCE) and all-cause mortality were determined during 5 years of follow-up. Cox proportional hazard modeling was used to adjust for baseline differences between patients with and without concomitant CAD. Despite a higher adherence to GDMT (all p less than or equal to 0.002) for the use of aspirin, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, and statins, patients with PAD and concomitant CAD had higher unadjusted 5-year rates of MACCE (hazard ratio [HR] 1.7, 95% CI 1.3 to 2.1, p = 0.0001) and all-cause mortality (HR 1.86, 95% CI 1.4 to 2.4, p = 0.0001). After adjustment for baseline co-morbidities, the presence of CAD remained an independent risk factor for mortality (adjusted HR 1.35, 95% CI 1.02 to 1.80, p = 0.04) but not for MACCE (adjusted HR 1.24, 95% CI 0.96 to 1.60, p = 0.10) in patients with PAD. A sensitivity analysis limited to patients with CLI demonstrated that concomitant CAD was associated with significantly higher adjusted rates of both MACCE (adjusted HR 1.52, 95% CI 1.14 to 2.03, p = 0.01) and mortality (adjusted HR 1.64, 95% CI 1.12 to 2.20, p = 0.006). In conclusion, despite higher rates of GDMT use, PAD patients with concomitant CAD had significantly increased risk of all-cause mortality during a 5-year postprocedural follow-up. The subgroup of CLI patients with concomitant CAD was at particularly high risk for both MACCE and all-cause mortality. There are limited contemporary data on guideline-directed medical therapy (GDMT) utilization and long-term clinical outcomes in patients with peripheral artery disease (PAD) with and without concomitant coronary artery disease (CAD). From 2006 to 2013, 879 patients with claudication or critical limb ischemia (CLI) underwent diagnostic angiography or therapeutic endovascular intervention at our multidisciplinary vascular center. GDMT use was assessed at the time of angiography, and major adverse cardiovascular and cerebrovascular events (MACCE) and all-cause mortality were determined during 5 years of follow-up. Cox proportional hazard modeling was used to adjust for baseline differences between patients with and without concomitant CAD. Despite a higher adherence to GDMT (all p ≤0.002) for the use of aspirin, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, and statins, patients with PAD and concomitant CAD had higher unadjusted 5-year rates of MACCE (hazard ratio [HR] 1.7, 95% CI 1.3 to 2.1, p = 0.0001) and all-cause mortality (HR 1.86, 95% CI 1.4 to 2.4, p = 0.0001). After adjustment for baseline co-morbidities, the presence of CAD remained an independent risk factor for mortality (adjusted HR 1.35, 95% CI 1.02 to 1.80, p = 0.04) but not for MACCE (adjusted HR 1.24, 95% CI 0.96 to 1.60, p = 0.10) in patients with PAD. A sensitivity analysis limited to patients with CLI demonstrated that concomitant CAD was associated with significantly higher adjusted rates of both MACCE (adjusted HR 1.52, 95% CI 1.14 to 2.03, p = 0.01) and mortality (adjusted HR 1.64, 95% CI 1.12 to 2.20, p = 0.006). In conclusion, despite higher rates of GDMT use, PAD patients with concomitant CAD had significantly increased risk of all-cause mortality during a 5-year postprocedural follow-up. The subgroup of CLI patients with concomitant CAD was at particularly high risk for both MACCE and all-cause mortality. |
| Author | Armstrong, Ehrin J. Laird, John R. Amsterdam, Ezra A. Waldo, Stephen W. Chen, Debbie C. Singh, Gagan D. |
| Author_xml | – sequence: 1 givenname: Debbie C. surname: Chen fullname: Chen, Debbie C. organization: Department of Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts – sequence: 2 givenname: Gagan D. surname: Singh fullname: Singh, Gagan D. organization: Division of Cardiovascular Medicine, Department of Internal Medicine, University of California Davis Vascular Center, Sacramento, California – sequence: 3 givenname: Ehrin J. surname: Armstrong fullname: Armstrong, Ehrin J. organization: Division of Cardiology, University of Colorado, Veterans Administration Eastern Colorado Healthcare System, Denver, Colorado – sequence: 4 givenname: Stephen W. surname: Waldo fullname: Waldo, Stephen W. organization: Division of Cardiology, University of Colorado, Veterans Administration Eastern Colorado Healthcare System, Denver, Colorado – sequence: 5 givenname: John R. surname: Laird fullname: Laird, John R. organization: Division of Cardiovascular Medicine, Department of Internal Medicine, University of California Davis Vascular Center, Sacramento, California – sequence: 6 givenname: Ezra A. surname: Amsterdam fullname: Amsterdam, Ezra A. email: eaamsterdam@ucdavis.edu organization: Division of Cardiovascular Medicine, Department of Internal Medicine, University of California Davis Vascular Center, Sacramento, California |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28259239$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNUl1rFDEUDVKx2-pPUAZ88WXGfMxXECtl6xcstGDFx5BJ7tisM8maZAp98bc3424RF2R9yk1yzsm95-QEHVlnAaHnBBcEk_r1upDjWkmvC5q2BaEFpuwRWpC24TnhhB2hBcaY5pyU_BidhLBOW0Kq-gk6pi2tOGV8gX6tnP2eX4Mfs6UbN9LLaG4hu5yiciOEzPXZVToCG0P2zcSb7Aq82dyAl0N27iP4u-zCBJABttfS6t-Fm2IStEnERGnn2jsrE_pv0lP0uJdDgGe79RR9_fD-evkpX11-_Lw8X-WqYlXMFWWKd5w0WBNFaFdjrCglXSOl7Luyw1r3qgZMtVYUWCIRXgFWJW51Rxhnp-jVVnfj3c8JQhSjCQqGQVpwUxCkbVtetzx5eBjalE2Lq6pJ0Jd70LWbvE2DzIIlbSqGy4R6sUNN3QhabLwZkxPiIYQEeLMFKO9C8NALlUyLxtnopRkEwWKOXKzFLnIxRy4IFandxK722A8PHOK92_Ig-X5rwIugUs4KtPGgotDOHFQ421NQg7FGyeEH3EH444UIiSC-zN9x_o2kYRiX5Tz4238L_EcD90Lg8lg |
| CitedBy_id | crossref_primary_10_1016_j_amjmed_2018_07_006 crossref_primary_10_1016_j_jacl_2018_02_013 crossref_primary_10_1371_journal_pone_0321491 crossref_primary_10_1016_j_cjca_2020_04_013 crossref_primary_10_18621_eurj_925688 crossref_primary_10_1016_j_amjcard_2020_04_043 crossref_primary_10_1080_00015385_2019_1653565 crossref_primary_10_1161_CIRCULATIONAHA_117_032235 crossref_primary_10_1016_j_ancard_2020_07_002 crossref_primary_10_1016_j_cjca_2025_05_002 crossref_primary_10_1007_s00392_017_1185_z crossref_primary_10_1016_j_eclinm_2025_103391 crossref_primary_10_1016_j_jacc_2024_02_013 crossref_primary_10_1177_1526602820935611 crossref_primary_10_3390_jcm11226619 crossref_primary_10_1097_HCR_0000000000000559 crossref_primary_10_1161_CIR_0000000000001251 crossref_primary_10_2147_VHRM_S246528 crossref_primary_10_1007_s00270_019_02324_4 crossref_primary_10_1016_S1878_6480_19_30446_X crossref_primary_10_3389_fcvm_2022_853583 crossref_primary_10_3390_jcm12103410 crossref_primary_10_1016_j_atherosclerosis_2021_09_022 crossref_primary_10_1016_j_avsg_2022_01_024 crossref_primary_10_1016_j_carrev_2021_05_011 crossref_primary_10_1016_j_jvs_2023_05_006 |
| Cites_doi | 10.1097/00000658-198402000-00016 10.1136/bmj.324.7329.71 10.1093/eurheartj/ehl114 10.1001/jama.2010.1322 10.1161/CIRCULATIONAHA.106.174526 10.1007/s11606-006-5042-4 10.1161/CIRCULATIONAHA.110.003954 10.1177/1358863X15574321 10.1016/S0140-6736(02)09327-3 10.1161/CIR.0b013e31822e80c3 10.1056/NEJM200001203420301 10.1161/CIRCOUTCOMES.109.930735 10.1161/JAHA.113.000697 10.1016/j.jacc.2013.09.073 10.1016/j.jacc.2005.09.074 10.1177/1358863X10373299 10.1097/MCA.0000000000000044 10.1016/j.jacc.2011.10.824 10.1002/clc.22217 10.1001/jama.297.11.1197 10.1016/j.jvs.2015.01.051 10.1177/2047487313519344 10.1177/1358863X13475836 10.1177/1358836X0100600i103 10.1161/CIRCULATIONAHA.112.108787 |
| ContentType | Journal Article |
| Copyright | 2017 Elsevier Inc. Elsevier Inc. Copyright © 2017 Elsevier Inc. All rights reserved. Copyright Elsevier Limited Apr 15, 2017 |
| Copyright_xml | – notice: 2017 Elsevier Inc. – notice: Elsevier Inc. – notice: Copyright © 2017 Elsevier Inc. All rights reserved. – notice: Copyright Elsevier Limited Apr 15, 2017 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7TS 7X7 7XB 88E 8FD 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH K9. KB0 M0S M1P M2O M7Z MBDVC NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 7QO |
| DOI | 10.1016/j.amjcard.2016.12.023 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Physical Education Index ProQuest_Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Proquest Research Library Biochemistry Abstracts 1 Research Library (Corporate) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic Biotechnology Research Abstracts |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central China Physical Education Index ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Biochemistry Abstracts 1 ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic Biotechnology Research Abstracts |
| DatabaseTitleList | Research Library Prep MEDLINE Engineering Research Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7RV name: Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1879-1913 |
| EndPage | 1152 |
| ExternalDocumentID | 28259239 10_1016_j_amjcard_2016_12_023 S0002914917300449 1_s2_0_S0002914917300449 |
| Genre | Journal Article Comparative Study |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 23M 4.4 457 4G. 53G 5RE 5VS 6J9 7-5 71M 7RV 7X7 88E 8FI 8FJ 8G5 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAQFI AAQQT AATTM AAWTL AAXKI AAXUO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABPPZ ABUWG ACDAQ ACGFO ACGFS ACIEU ACIUM ACIWK ACLOT ACPRK ACRLP ACVFH ADBBV ADCNI ADEZE ADFRT ADUKH AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHMBA AIEXJ AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR AZQEC BENPR BKEYQ BKOJK BKOMP BLXMC BNPGV BPHCQ BVXVI CCPQU CS3 DWQXO EBS EFJIC EFKBS EFLBG EJD EO9 EP2 EP3 EX3 F5P FDB FIRID FNPLU FYGXN FYUFA G-Q GBLVA GNUQQ GUQSH HMCUK IH2 IHE J1W J5H K-O KOM L7B M1P M29 M2O M41 MO0 N9A NAPCQ O-L O9- OA. OAUVE OL~ OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO Q38 ROL RPZ SDF SDG SEL SES SJN SPCBC SSH SSZ T5K TWZ UKHRP UNMZH UV1 WH7 WOW YFH YOC YZZ Z5R ~G- ~HD .55 .GJ 1CY 3O- 3V. AACTN AAQXK AAYOK ABWVN ABXDB ACRPL ADMUD ADNMO AFCTW AFFNX AFJKZ AFKWA AHHHB AJOXV ALIPV AMFUW ASPBG AVWKF AZFZN EMOBN FEDTE FGOYB G-2 HEB HMK HMO HVGLF HZ~ OHT OVD PKN R2- RIG SAE SV3 TEORI WUQ X7M XPP YQJ YYP ZGI ZXP AAIAV ABLVK ABYKQ AJBFU LCYCR ZA5 9DU AAYWO AAYXX AFFHD AGQPQ AIGII CITATION CGR CUY CVF ECM EIF NPM 7TS 7XB 8FD 8FK FR3 K9. M7Z MBDVC P64 PKEHL PQEST PQUKI PRINS Q9U 7X8 7QO |
| ID | FETCH-LOGICAL-c535t-c23c9b9170d1c12b600c221b7aaafb4b0ddfc6e02ddc2e3c53195e0c408db1393 |
| IEDL.DBID | 7RV |
| ISICitedReferencesCount | 29 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000399515000004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0002-9149 |
| IngestDate | Tue Oct 07 09:32:39 EDT 2025 Sun Nov 09 09:27:18 EST 2025 Tue Oct 07 06:02:58 EDT 2025 Thu Apr 03 07:09:17 EDT 2025 Tue Nov 18 21:53:36 EST 2025 Sat Nov 29 06:43:10 EST 2025 Fri Feb 23 02:17:22 EST 2024 Tue Feb 25 19:58:27 EST 2025 Tue Oct 14 19:31:19 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Language | English |
| License | Copyright © 2017 Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c535t-c23c9b9170d1c12b600c221b7aaafb4b0ddfc6e02ddc2e3c53195e0c408db1393 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
| PMID | 28259239 |
| PQID | 1884275304 |
| PQPubID | 41200 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_1888968902 proquest_miscellaneous_1874780557 proquest_journals_1884275304 pubmed_primary_28259239 crossref_citationtrail_10_1016_j_amjcard_2016_12_023 crossref_primary_10_1016_j_amjcard_2016_12_023 elsevier_sciencedirect_doi_10_1016_j_amjcard_2016_12_023 elsevier_clinicalkeyesjournals_1_s2_0_S0002914917300449 elsevier_clinicalkey_doi_10_1016_j_amjcard_2016_12_023 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-04-15 |
| PublicationDateYYYYMMDD | 2017-04-15 |
| PublicationDate_xml | – month: 04 year: 2017 text: 2017-04-15 day: 15 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: New York |
| PublicationTitle | The American journal of cardiology |
| PublicationTitleAlternate | Am J Cardiol |
| PublicationYear | 2017 |
| Publisher | Elsevier Inc Elsevier Limited |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited |
| References | Smith, Benjamin, Bonow, Braun, Creager, Franklin, Gibbons, Grundy, Hiratzka, Jones, Lloyd-Jones, Minissian, Mosca, Peterson, Sacco, Spertus, Stein, Taubert (bib8) 2011; 58 Armstrong, Chen, Westin, Singh, McCoach, Bang, Yeo, Anderson, Amsterdam, Laird (bib15) 2014; 3 Subherwal, Patel, Kober, Peterson, Bhatt, Gislason, Olsen, Jones, Torp-Pedersen, Fosbol (bib1) 2015; 22 Mahoney, Wang, Keo, Duval, Smolderen, Cohen, Steg, Bhatt, Hirsch (bib4) 2010; 3 Armstrong, Chen, Singh, Amsterdam, Laird (bib16) 2015; 20 Pereg, Elis, Neuman, Mosseri, Segev, Granek-Catarivas, Lishner, Hermoni (bib5) 2014; 25 Fowkes, Low, Tuta, Kozak (bib27) 2006; 27 Hertzer, Beven, Young, O'Hara, Ruschhaupt, Graor, Dewolfe, Maljovec (bib19) 1984; 199 Bhatt, Eagle, Ohman, Hirsch, Goto, Mahoney, Wilson, Alberts, D'Agostino, Liau, Mas, Röther, Smith, Salette, Contant, Massaro, Steg (bib21) 2010; 304 Bhatt (bib20) 2003; 15 Hirsch, Haskal, Hertzer, Bakal, Creager, Halperin, Hiratzka, Murphy, Olin, Puschett, Rosenfield, Sacks, Stanley, Taylor, White, White, White (bib7) 2006; 113 Hirsch, Hiatt (bib10) 2001; 6 Suarez, Zeymer, Limbourg, Baumgartner, Cacoub, Poldermans, Rother, Bhatt, Steg (bib13) 2010; 15 Gerhard-Herman, Gornik, Barrett, Barshes, Corriere, Drachman, Fleisher, Fowkes, Hamburg, Kinlay, Lookstein, Misra, Mureebe, Olin, Patel, Regensteiner, Schanzer, Shishehbor, Stewart, Treat-Jacobson, Walsh (bib26) 2016 McCoach, Armstrong, Singh, Javed, Anderson, Yeo, Westin, Hedayati, Amsterdam, Laird (bib14) 2013; 18 Steg, Bhatt, Wilson, D'Agostino, Ohman, Röther, Liau, Hirsch, Mas, Ikeda, Pencina, Goto (bib2) 2007; 297 Rodriguez, Cannon, Steg, Kumbhani, Goto, Smith, Eagle, Ohman, Umez-Eronini, Hoffman, Bhatt (bib12) 2013; 36 Yusuf, Sleight, Pogue, Bosch, Davies, Dagenais (bib25) 2000; 342 Feringa, van Waning, Bax, Elhendy, Boersma, Schouten, Galal, Vidakovic, Tangelder, Poldermans (bib22) 2006; 47 Westin, Armstrong, Bang, Yeo, Anderson, Dawson, Pevec, Amsterdam, Laird (bib17) 2014; 63 Armstrong, Anderson, Yeo, Singh, Bang, Amsterdam, Freischlag, Laird (bib18) 2015; 62 Rooke, Hirsch, Misra, Sidawy, Beckman, Findeiss, Golzarian, Gornik, Halperin, Jaff, Moneta, Olin, Stanley, White, White, Zierler (bib6) 2011; 124 (bib23) 2002; 324 Subherwal, Patel, Kober, Peterson, Jones, Gislason, Berger, Torp-Pedersen, Fosbol (bib11) 2012; 126 McDermott, Mehta, Ahn, Greenland (bib3) 1997; 12 (bib24) 2002; 360 Pande, Perlstein, Beckman, Creager (bib9) 2011; 124 Subherwal (10.1016/j.amjcard.2016.12.023_bib1) 2015; 22 McCoach (10.1016/j.amjcard.2016.12.023_bib14) 2013; 18 (10.1016/j.amjcard.2016.12.023_bib23) 2002; 324 Suarez (10.1016/j.amjcard.2016.12.023_bib13) 2010; 15 Fowkes (10.1016/j.amjcard.2016.12.023_bib27) 2006; 27 Subherwal (10.1016/j.amjcard.2016.12.023_bib11) 2012; 126 Armstrong (10.1016/j.amjcard.2016.12.023_bib16) 2015; 20 Yusuf (10.1016/j.amjcard.2016.12.023_bib25) 2000; 342 Gerhard-Herman (10.1016/j.amjcard.2016.12.023_bib26) 2016 Rooke (10.1016/j.amjcard.2016.12.023_bib6) 2011; 124 Pande (10.1016/j.amjcard.2016.12.023_bib9) 2011; 124 Steg (10.1016/j.amjcard.2016.12.023_bib2) 2007; 297 Armstrong (10.1016/j.amjcard.2016.12.023_bib18) 2015; 62 Bhatt (10.1016/j.amjcard.2016.12.023_bib20) 2003; 15 Smith (10.1016/j.amjcard.2016.12.023_bib8) 2011; 58 Hirsch (10.1016/j.amjcard.2016.12.023_bib10) 2001; 6 Pereg (10.1016/j.amjcard.2016.12.023_bib5) 2014; 25 Rodriguez (10.1016/j.amjcard.2016.12.023_bib12) 2013; 36 McDermott (10.1016/j.amjcard.2016.12.023_bib3) 1997; 12 Westin (10.1016/j.amjcard.2016.12.023_bib17) 2014; 63 Bhatt (10.1016/j.amjcard.2016.12.023_bib21) 2010; 304 Feringa (10.1016/j.amjcard.2016.12.023_bib22) 2006; 47 Armstrong (10.1016/j.amjcard.2016.12.023_bib15) 2014; 3 Hirsch (10.1016/j.amjcard.2016.12.023_bib7) 2006; 113 Mahoney (10.1016/j.amjcard.2016.12.023_bib4) 2010; 3 Hertzer (10.1016/j.amjcard.2016.12.023_bib19) 1984; 199 (10.1016/j.amjcard.2016.12.023_bib24) 2002; 360 |
| References_xml | – volume: 36 start-page: 721 year: 2013 end-page: 727 ident: bib12 article-title: REACH registry investigators. Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH registry publication-title: Clin Cardiol – volume: 15 start-page: 259 year: 2010 end-page: 265 ident: bib13 article-title: Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH registry publication-title: Vasc Med – volume: 63 start-page: 682 year: 2014 end-page: 690 ident: bib17 article-title: Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia publication-title: J Am Coll Cardiol – volume: 199 start-page: 223 year: 1984 end-page: 233 ident: bib19 article-title: Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management publication-title: Ann Surg – volume: 25 start-page: 79 year: 2014 end-page: 82 ident: bib5 article-title: Comparison of mortality in patients with coronary or peripheral artery disease following the first vascular intervention publication-title: Coron Artery Dis – volume: 126 start-page: 1345 year: 2012 end-page: 1354 ident: bib11 article-title: Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains publication-title: Circulation – volume: 12 start-page: 209 year: 1997 end-page: 215 ident: bib3 article-title: Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease publication-title: J Gen Intern Med – volume: 15 start-page: 3B year: 2003 end-page: 9B ident: bib20 article-title: Diffuse coronary disease and atherothrombosis: a rationale for long-term therapy to prevent recurrent ischemic events publication-title: J Invasive Cardiol – year: 2016 ident: bib26 article-title: 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines publication-title: Circulation – volume: 324 start-page: 71 year: 2002 end-page: 86 ident: bib23 article-title: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients publication-title: BMJ – volume: 20 start-page: 237 year: 2015 end-page: 244 ident: bib16 article-title: Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia publication-title: Vasc Med – volume: 124 start-page: 17 year: 2011 end-page: 23 ident: bib9 article-title: Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004 publication-title: Circulation – volume: 6 start-page: 9 year: 2001 end-page: 12 ident: bib10 article-title: PAD awareness, risk, and treatment: new resources for survival–the USA PARTNERS program publication-title: Vasc Med Lond Engl – volume: 18 start-page: 19 year: 2013 end-page: 26 ident: bib14 article-title: Gender-related variation in the clinical presentation and outcomes of critical limb ischemia publication-title: Vasc Med – volume: 22 start-page: 317 year: 2015 end-page: 325 ident: bib1 article-title: Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study publication-title: Eur J Prev Cardiol – volume: 124 start-page: 2020 year: 2011 end-page: 2045 ident: bib6 article-title: 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines publication-title: Circulation – volume: 62 start-page: 157 year: 2015 end-page: 165.e1 ident: bib18 article-title: Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease publication-title: J Vasc Surg – volume: 342 start-page: 145 year: 2000 end-page: 153 ident: bib25 article-title: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators publication-title: N Engl J Med – volume: 58 start-page: 2432 year: 2011 end-page: 2446 ident: bib8 article-title: AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association publication-title: J Am Coll Cardiol – volume: 304 start-page: 1350 year: 2010 ident: bib21 article-title: Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis publication-title: JAMA – volume: 360 start-page: 7 year: 2002 end-page: 22 ident: bib24 article-title: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial publication-title: Lancet – volume: 27 start-page: 1861 year: 2006 end-page: 1867 ident: bib27 article-title: Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease: results of the international AGATHA study publication-title: Eur Heart J – volume: 47 start-page: 1182 year: 2006 end-page: 1187 ident: bib22 article-title: Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease publication-title: J Am Coll Cardiol – volume: 3 start-page: e000697 year: 2014 ident: bib15 article-title: Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease publication-title: J Am Heart Assoc – volume: 3 start-page: 642 year: 2010 end-page: 651 ident: bib4 article-title: Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States publication-title: Circ Cardiovasc Qual Outcomes – volume: 297 start-page: 1197 year: 2007 end-page: 1206 ident: bib2 article-title: One-year cardiovascular event rates in outpatients with atherothrombosis publication-title: JAMA – volume: 113 start-page: e463 year: 2006 end-page: e654 ident: bib7 article-title: ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic) a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery,* Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation publication-title: Circulation – volume: 199 start-page: 223 year: 1984 ident: 10.1016/j.amjcard.2016.12.023_bib19 article-title: Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management publication-title: Ann Surg doi: 10.1097/00000658-198402000-00016 – volume: 324 start-page: 71 year: 2002 ident: 10.1016/j.amjcard.2016.12.023_bib23 article-title: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients publication-title: BMJ doi: 10.1136/bmj.324.7329.71 – volume: 27 start-page: 1861 year: 2006 ident: 10.1016/j.amjcard.2016.12.023_bib27 article-title: Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease: results of the international AGATHA study publication-title: Eur Heart J doi: 10.1093/eurheartj/ehl114 – volume: 304 start-page: 1350 year: 2010 ident: 10.1016/j.amjcard.2016.12.023_bib21 article-title: Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis publication-title: JAMA doi: 10.1001/jama.2010.1322 – volume: 113 start-page: e463 year: 2006 ident: 10.1016/j.amjcard.2016.12.023_bib7 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.174526 – volume: 12 start-page: 209 year: 1997 ident: 10.1016/j.amjcard.2016.12.023_bib3 article-title: Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease publication-title: J Gen Intern Med doi: 10.1007/s11606-006-5042-4 – volume: 124 start-page: 17 year: 2011 ident: 10.1016/j.amjcard.2016.12.023_bib9 article-title: Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.110.003954 – volume: 20 start-page: 237 year: 2015 ident: 10.1016/j.amjcard.2016.12.023_bib16 article-title: Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia publication-title: Vasc Med doi: 10.1177/1358863X15574321 – volume: 360 start-page: 7 year: 2002 ident: 10.1016/j.amjcard.2016.12.023_bib24 article-title: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(02)09327-3 – volume: 124 start-page: 2020 year: 2011 ident: 10.1016/j.amjcard.2016.12.023_bib6 article-title: 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines publication-title: Circulation doi: 10.1161/CIR.0b013e31822e80c3 – volume: 342 start-page: 145 year: 2000 ident: 10.1016/j.amjcard.2016.12.023_bib25 article-title: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators publication-title: N Engl J Med doi: 10.1056/NEJM200001203420301 – volume: 3 start-page: 642 year: 2010 ident: 10.1016/j.amjcard.2016.12.023_bib4 article-title: Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States publication-title: Circ Cardiovasc Qual Outcomes doi: 10.1161/CIRCOUTCOMES.109.930735 – volume: 3 start-page: e000697 year: 2014 ident: 10.1016/j.amjcard.2016.12.023_bib15 article-title: Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease publication-title: J Am Heart Assoc doi: 10.1161/JAHA.113.000697 – volume: 63 start-page: 682 year: 2014 ident: 10.1016/j.amjcard.2016.12.023_bib17 article-title: Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.09.073 – volume: 47 start-page: 1182 year: 2006 ident: 10.1016/j.amjcard.2016.12.023_bib22 article-title: Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2005.09.074 – volume: 15 start-page: 259 year: 2010 ident: 10.1016/j.amjcard.2016.12.023_bib13 article-title: Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH registry publication-title: Vasc Med doi: 10.1177/1358863X10373299 – volume: 25 start-page: 79 year: 2014 ident: 10.1016/j.amjcard.2016.12.023_bib5 article-title: Comparison of mortality in patients with coronary or peripheral artery disease following the first vascular intervention publication-title: Coron Artery Dis doi: 10.1097/MCA.0000000000000044 – volume: 58 start-page: 2432 year: 2011 ident: 10.1016/j.amjcard.2016.12.023_bib8 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2011.10.824 – volume: 36 start-page: 721 year: 2013 ident: 10.1016/j.amjcard.2016.12.023_bib12 article-title: REACH registry investigators. Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH registry publication-title: Clin Cardiol doi: 10.1002/clc.22217 – volume: 297 start-page: 1197 year: 2007 ident: 10.1016/j.amjcard.2016.12.023_bib2 article-title: One-year cardiovascular event rates in outpatients with atherothrombosis publication-title: JAMA doi: 10.1001/jama.297.11.1197 – volume: 62 start-page: 157 year: 2015 ident: 10.1016/j.amjcard.2016.12.023_bib18 article-title: Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease publication-title: J Vasc Surg doi: 10.1016/j.jvs.2015.01.051 – year: 2016 ident: 10.1016/j.amjcard.2016.12.023_bib26 article-title: 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines publication-title: Circulation – volume: 22 start-page: 317 year: 2015 ident: 10.1016/j.amjcard.2016.12.023_bib1 article-title: Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study publication-title: Eur J Prev Cardiol doi: 10.1177/2047487313519344 – volume: 18 start-page: 19 year: 2013 ident: 10.1016/j.amjcard.2016.12.023_bib14 article-title: Gender-related variation in the clinical presentation and outcomes of critical limb ischemia publication-title: Vasc Med doi: 10.1177/1358863X13475836 – volume: 6 start-page: 9 year: 2001 ident: 10.1016/j.amjcard.2016.12.023_bib10 article-title: PAD awareness, risk, and treatment: new resources for survival–the USA PARTNERS program publication-title: Vasc Med Lond Engl doi: 10.1177/1358836X0100600i103 – volume: 126 start-page: 1345 year: 2012 ident: 10.1016/j.amjcard.2016.12.023_bib11 article-title: Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.108787 – volume: 15 start-page: 3B issue: Suppl B year: 2003 ident: 10.1016/j.amjcard.2016.12.023_bib20 article-title: Diffuse coronary disease and atherothrombosis: a rationale for long-term therapy to prevent recurrent ischemic events publication-title: J Invasive Cardiol |
| SSID | ssj0001156 |
| Score | 2.3692634 |
| Snippet | There are limited contemporary data on guideline-directed medical therapy (GDMT) utilization and long-term clinical outcomes in patients with peripheral artery... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1146 |
| SubjectTerms | Adrenergic beta-Antagonists - therapeutic use Age Aged Amputation Angiography Angiotensin-converting enzyme inhibitors Ankle Aspirin Aspirin - therapeutic use California - epidemiology Cardiovascular Cardiovascular disease Cardiovascular diseases Cardiovascular system Catheterization Cerebral infarction Cerebrovascular system Classification Clinical outcomes Clinical trials Collaboration Computer programs Congestive heart failure Coronary artery Coronary artery disease Coronary Artery Disease - drug therapy Coronary Artery Disease - mortality Coronary vessels Data processing Death Diabetes Mellitus - epidemiology Disease prevention Documentation Enzymes Female Follow-Up Studies Health risk assessment Heart attacks Heart Failure Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hypertension - epidemiology Ischemia Kidney diseases Kidney Failure, Chronic - epidemiology Male Mortality Myocardial Infarction - epidemiology Myocardial Revascularization - statistics & numerical data Pain Patients Peptidyl-dipeptidase A Peripheral Arterial Disease - drug therapy Peripheral Arterial Disease - mortality Pharmacy Platelet Aggregation Inhibitors - therapeutic use Proportional Hazards Models Retrospective Studies Risk Factors Sensitivity analysis Sex Factors Stroke Subgroups |
| Title | Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0002914917300449 https://www.clinicalkey.es/playcontent/1-s2.0-S0002914917300449 https://dx.doi.org/10.1016/j.amjcard.2016.12.023 https://www.ncbi.nlm.nih.gov/pubmed/28259239 https://www.proquest.com/docview/1884275304 https://www.proquest.com/docview/1874780557 https://www.proquest.com/docview/1888968902 |
| Volume | 119 |
| WOSCitedRecordID | wos000399515000004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: ScienceDirect database customDbUrl: eissn: 1879-1913 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001156 issn: 0002-9149 databaseCode: AIEXJ dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1879-1913 dateEnd: 20251006 omitProxy: false ssIdentifier: ssj0001156 issn: 0002-9149 databaseCode: 7X7 dateStart: 20120815 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1879-1913 dateEnd: 20251006 omitProxy: false ssIdentifier: ssj0001156 issn: 0002-9149 databaseCode: 7RV dateStart: 20120815 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1879-1913 dateEnd: 20251006 omitProxy: false ssIdentifier: ssj0001156 issn: 0002-9149 databaseCode: BENPR dateStart: 20120815 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library customDbUrl: eissn: 1879-1913 dateEnd: 20251006 omitProxy: false ssIdentifier: ssj0001156 issn: 0002-9149 databaseCode: M2O dateStart: 20120815 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5Bi1AvvB8LpQoS17SO7bxOCEorDu12VQrszXJsL-yqJGWTReLCb2cmcbISoi0SlyireOxo58v4G489A_BKaGMTZuMwFgU6KLqwYcGZCG0RORlLKYVrq5YcpeNxNp3mE7_gVvttlb1NbA21rQytke9FWSY5cmsmX198D6lqFEVXfQmNm7AZ0dyNeE5PPw2WGNlO0tPfHF2B9QmevcWu_rYwqATa3ZW0K4JcXDY3XcY92zno8O7_vv09uOPZZ_Cmg8t9uOHKB3D72MfXH8Kvo6r8Ep6htQ7212nBg5NVg8O4OqhmwaRLxFoHn-fN12CCAG4TE7SduuXP4F0X8eke69K2N9WqwQ5L7GROVYvxflnROeA_hB7Bx8ODs_33oa_QEJpYxE1ouDB5gR4fs5GJeIHsyXAeFanWelbIglk7M4lj3FrDnTD0wceOGckyBIPIxWPYKKvSPYVAI5FIpOOxRhfPsFSjFXYyl2KWaWEdG4HsdaOMT19OVTTOVb9PbaG8ShWpVEVcoUpHsDuIXXT5O64TSHrFq_5wKppThTPMdYLp3wRd7Y1CrSJVY0v1gfBIcIyoVoCU-QiyQdLzno7P_Mug2z3e1HqcAWwjeDk8RrNBsSBdumpFbahwAiVgu6pNluUJBaJH8KTD_fAf0pFn9A3yZ1e_wHPY4sSDKDlmvA0bzXLlXsAt86OZ18ud9mul6zRtr9kObL49GE9O8dcxP_kNABNMzg |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLaqgqAX9iVQwEhwTOvYznZACLVUrTodRmIQczOO7aEzgqRMMqBe-En8Rt7LNhKiLZceuEWynx0nn99iv4WQF0IbGzEb-qHIwEDRmfUzzoRvs8DJUEopXF21ZBAPh8lkko7WyK8uFgbdKjueWDNqWxg8I98OkkRy0K2ZfH3yzceqUXi72pXQaGBx6E5_gMlWvjrYhf_7kvO9t-Odfb-tKuCbUISVb7gwaQZWCrOBCXgGEt9wHmSx1nqayYxZOzWRY9xaw50wCNLQMSNZAgsQmHwJWP4V4OMxupDFk97AQ-0q6tTtFEyPVcTQ9nxLf50b-OnoTRbVJ5BcnCULz9J1a5m3d_N_-1q3yI1Wu6Zvmu1wm6y5_A65dtT6D9wlPwdF_tkfgzSiO6u05_TdsoJluZIWUzpqEs2W9OOsOqYj2KB14oV6ULc4pbvNjVbTrHNbPxTLCgbMYZAZVmWG50WBcc5_EN0jHy5l9ffJel7k7iGhGhSlSDoeajBhDYs1SBknUymmiRbWMY_IDgvKtOnZsUrIF9X54c1VCyGFEFIBVwAhj2z1ZCdNfpKLCKIOaKoLvgVxoUCCXkQY_43QlS3TK1WgSuip3iP-Ef4B1kKQMvVI0lO2el2jr_3LpJsdvtVqnh7cHnneNwNbxLsunbtiiX2wMAQmmDuvT5KkEV60e-RBs8_6b4gh3WD7pI_Of4Fn5Pr--GigBgfDw8dkg6POh4lAw02yXi2W7gm5ar5Xs3LxtOYUlHy67M32G-j-ppE |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLaqgiou7MtAASPBMR3HdrYDQqjDiKrDMBJFzM04tgMzgqRMMqBe-GH8Ot7LNhKiLZceuEWKnxMn39vstxDyVGhjQ2YDLxApOCg6tV7KmfBs6jsZSCmFq7uWTKLpNJ7Pk9kW-dXlwmBYZScTa0FtC4N75EM_jiUH25rJYdaGRcxG4xfH3zzsIIUnrV07jQYih-7kB7hv5fODEfzrZ5yPXx3tv_baDgOeCURQeYYLk6TgsTDrG5-noP0N534aaa2zVKbM2syEjnFrDXfCIGADx4xkMSxGYCEmEP-XIiEibBsRzXtnDy2tsDO9E3BDNtlDw-We_ro0AACMLAvr3UguTtOLp9m9tf4bX_ufv9x1crW1uunLhk1ukC2X3yQ7b9q4glvk56TIP3lHoKXo_qYcOn27rmCJrqRFRmdNAdqSflhUn-kMGLcuyFBP6lYndNScdDW3dW7ri2JdwYQ5TLLAbs1wvSow__kPotvk_YWs_g7Zzovc3SNUgwEVSscDDa6tYZEG7eNkIkUWa2EdGxDZ4UKZtmw7dg_5orr4vKVq4aQQTsrnCuA0IHs92XFTt-Q8grADneqSckGNKNCs5xFGfyN0ZSsMS-WrEkaqd8gLyAo-9kiQMhmQuKds7b3GjvuXh-52WFeb5_RAH5An_W0Ql3gGpnNXrHEMNozAwnNnjYnjJMQD-AG52_Bc_w0x1Rt8ouT-2S_wmOwAj6nJwfTwAbnC0RTE-qDBLtmuVmv3kFw236tFuXpUCw1KPl40r_0GKyevRQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-Term+Comparative+Outcomes+of+Patients+With+Peripheral+Artery+Disease+With+and+Without+Concomitant+Coronary+Artery+Disease&rft.jtitle=The+American+journal+of+cardiology&rft.au=Chen%2C+Debbie+C&rft.au=Singh%2C+Gagan+D&rft.au=Armstrong%2C+Ehrin+J&rft.au=Waldo%2C+Stephen+W&rft.date=2017-04-15&rft.issn=0002-9149&rft.volume=119&rft.issue=8&rft.spage=1146&rft.epage=1152&rft_id=info:doi/10.1016%2Fj.amjcard.2016.12.023&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9149&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9149&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9149&client=summon |